Suppr超能文献

氯胺酮与依托咪酯在危重症成人气管插管诱导中的比较:一项贝叶斯荟萃分析。

Ketamine versus etomidate as an induction agent for tracheal intubation in critically ill adults: a Bayesian meta-analysis.

机构信息

Department of Intensive Care Medicine, Kameda Medical Center, 929 Higashi-cho, Kamogawa, 296-8602, Japan.

Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.

出版信息

Crit Care. 2024 Feb 17;28(1):48. doi: 10.1186/s13054-024-04831-4.

Abstract

BACKGROUND

Tracheal intubation is a high-risk intervention commonly performed in critically ill patients. Due to its favorable cardiovascular profile, ketamine is considered less likely to compromise clinical outcomes. This meta-analysis aimed to assess whether ketamine, compared with other agents, reduces mortality in critically ill patients undergoing intubation.

METHODS

We searched MEDLINE, Embase, and the Cochrane Library from inception until April 27, 2023, for randomized controlled trials and matched observational studies comparing ketamine with any control in critically ill patients as an induction agent. The primary outcome was mortality at the longest follow-up available, and the secondary outcomes included Sequential Organ Failure Assessment score, ventilator-free days at day 28, vasopressor-free days at day 28, post-induction mean arterial pressure, and successful intubation on the first attempt. For the primary outcome, we used a Bayesian random-effects meta-analysis on the risk ratio (RR) scale with a weakly informative neutral prior corresponding to a mean estimate of no difference with 95% probability; the estimated effect size will fall between a relative risk of 0.25 and 4. The RR and 95% credible interval (CrI) were used to estimate the probability of mortality reduction (RR < 1). The secondary outcomes were assessed with a frequentist random-effects model. We registered this study in Open Science Framework ( https://osf.io/2vf79/ ).

RESULTS

We included seven randomized trials and one propensity-matched study totaling 2978 patients. Etomidate was the comparator in all the identified studies. The probability that ketamine reduced mortality was 83.2% (376/1475 [25%] vs. 411/1503 [27%]; RR, 0.93; 95% CrI, 0.79-1.08), which was confirmed by a subgroup analysis excluding studies with a high risk of bias. No significant difference was observed in any secondary outcomes.

CONCLUSIONS

All of the included studies evaluated ketamine versus etomidate among critically ill adults requiring tracheal intubation. This meta-analysis showed a moderate probability that induction with ketamine is associated with a reduced risk of mortality.

摘要

背景

气管插管是危重病患者中常见的高风险干预措施。由于其心血管特性有利,氯胺酮被认为不太可能影响临床结果。这项荟萃分析旨在评估氯胺酮与其他药物相比,是否会降低接受插管的危重病患者的死亡率。

方法

我们从 MEDLINE、Embase 和 Cochrane 图书馆检索了截至 2023 年 4 月 27 日的随机对照试验和配对观察性研究,比较了氯胺酮与任何作为诱导剂的对照药物在危重病患者中的应用。主要结局是最长随访期的死亡率,次要结局包括序贯器官衰竭评估评分、第 28 天无呼吸机天数、第 28 天无血管加压素天数、诱导后平均动脉压和首次尝试插管成功。对于主要结局,我们使用贝叶斯随机效应荟萃分析,在风险比(RR)尺度上进行分析,使用一个弱信息中性先验,对应于无差异的平均估计值,概率为 95%,估计的效应量将在相对风险 0.25 到 4 之间。RR 和 95%可信区间(CrI)用于估计死亡率降低的概率(RR<1)。次要结局采用频率随机效应模型进行评估。我们在 Open Science Framework(https://osf.io/2vf79/)上注册了这项研究。

结果

我们纳入了 7 项随机试验和 1 项倾向匹配研究,共纳入 2978 例患者。所有研究中,依托咪酯均作为对照药物。使用氯胺酮降低死亡率的概率为 83.2%(1475 例中的 376 例[25%]与 1503 例中的 411 例[27%];RR,0.93;95% CrI,0.79-1.08),这一结果通过排除高偏倚风险研究的亚组分析得到了证实。在任何次要结局中均未观察到显著差异。

结论

所有纳入的研究均评估了气管插管的危重病成人中,使用氯胺酮与依托咪酯的情况。这项荟萃分析显示,使用氯胺酮诱导与降低死亡率的风险之间存在中等程度的关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b153/10874027/6cc08479c98c/13054_2024_4831_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验